Open Internet by MindsNet

Ensuring the reliability and integrity of clinical trial data

The retraction of a phase 3 clinical trial on using mesenchymal stem cells to prevent heart failure after myocardial infarction highlights concerns about trial design, conduct, and data reporting. These issues raise questions about the reliability and integrity of clinical trial data, which is crucial for medical advancements. Addressing these concerns is essential to maintain trust in clinical research and ensure patient safety.

Science, Medicine, Cardiology